Jie Zha
- Cancer Research top 10%
- Hematology top 10%
- Acute Myeloid Leukemia Research 18
- Chronic Myeloid Leukemia Treatments 6
-
- Histone Deacetylase Inhibitors Research 12
- Protein Degradation and Inhibitors 6
-
- Immune Cell Function and Interaction 8
-
- Lymphoma Diagnosis and Treatment 9
-
- Chronic Lymphocytic Leukemia Research 6
-
- Acute Lymphoblastic Leukemia research 6
- Co-authors
- Bing XuManman DengRongwei LiHuijuan DongWeiguang WangKai ChenPeng LiVinodh Kannappan
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jie Zha
44 papers receiving 757 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 199
- Hematology 142
- Molecular Biology 454
- Immunology 134
- Oncology 142
Countries citing papers authored by Jie Zha
This map shows the geographic impact of Jie Zha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Zha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Zha more than expected).
Fields of papers citing papers by Jie Zha
This network shows the impact of papers produced by Jie Zha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Zha. The network helps show where Jie Zha may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jie Zha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 15 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 0 | |
| 10 | 2022 | 4 | |
| 11 | 2020 | 25 | |
| 12 | 2020 | 16 | |
| 13 | 2020 | 5 | |
| 14 | 2020 | 8 | |
| 15 | 2020 | 4 | |
| 16 | 2017 | 110 | |
| 17 | 2017 | 20 | |
| 18 | 2014 | 12 | |
| 19 | 2014 | 89 | |
| 20 | 2009 | 8 |
About Jie Zha
Jie Zha is a scholar working on Hematology, Immunology and Genetics, having authored 50 papers that have together received 760 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (18 papers), Histone Deacetylase Inhibitors Research (12 papers), Lymphoma Diagnosis and Treatment (9 papers), Immune Cell Function and Interaction (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Protein Degradation and Inhibitors (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). The work is most often cited by research in Cancer Research (199 citations), Hematology (142 citations) and Molecular Biology (454 citations). Jie Zha has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Bing Xu, Manman Deng, Rongwei Li, Huijuan Dong, Weiguang Wang, Kai Chen, Peng Li, Vinodh Kannappan, Lingli He and Shiyun Wang. Their work appears in journals such as Blood, Cancer Cell and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.